Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-24-000071

President & CEO sold 30,000 shares at $47.87 ($1,436,100)

From the SEC's structured data for this filing

Trades in this filing

KAKKIS EMIL D · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-29 Sale : show line 1 in the form −30,000 $47.87 $1,436,100 569,770 D
Open-market sales · 30,000 sh · avg $47.87 · $1,436,100
Loading xslF345X05/doc4.xml…